Description
Venlafaxine 50 mg Immediate Release Tablets is available by prescription only. Go ahead and place your purchase. After making payment, we will ensure that a valid prescription is received from your prescriber.
Drug Label Highlights
Source: This information is taken from the official DailyMed drug label page when available. It is provided for educational purposes and is not a substitute for pharmacist counseling, prescriber instructions, or the full official labeling.
Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of venlafaxine tablets or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Venlafaxine tablets are not approved for use in pediatric patients (see WARNINGS: Clinical Worsening and Suicide Risk, PRECAUTIONS: Information for Patients, and PRECAUTIONS: Pediatric Use).
DailyMed highlights last updated: 2026-06-24 22:33:38
Medication Guide
Medication Summary
Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.
Overview
Venlafaxine tablets, USP are an oral antidepressant used to treat major depressive disorder. The label describes venlafaxine as a structurally novel antidepressant and notes that its active metabolite is O-desmethylvenlafaxine (ODV).
The medicine is not approved for use in pediatric patients. The label also says patients should be monitored for worsening depression, suicidal thoughts or behavior, and unusual changes in behavior, especially when treatment starts or the dose changes.
Venlafaxine should not be used with MAOIs intended to treat psychiatric disorders, or within certain time windows around MAOI use, because of the risk of serotonin syndrome. The label also warns about sustained increases in blood pressure, angle-closure glaucoma, discontinuation symptoms, and possible sexual side effects.
Storage Information
protection, if needed, may be indicated if performed soon after ingestion or in symptomatic patients. Storage Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature] in a dry place. Dispense in a well-closed container as defined in the USP. store venlafaxine tablets? Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature].
Key Counseling Points
- Take venlafaxine exactly as prescribed.
- Do not stop taking it suddenly unless your prescriber tells you to; the label says abrupt stopping can cause withdrawal symptoms.
- Watch for worsening depression, suicidal thoughts, unusual behavior changes, agitation, irritability, or insomnia, especially early in treatment or when the dose changes.
- Tell your prescriber about all medicines and supplements you take, especially MAOIs and other serotonergic drugs, because of serotonin syndrome risk.
- Know the symptoms of serotonin syndrome, which can include agitation, hallucinations, fast heart rate, blood pressure changes, tremor, rigidity, fever, nausea, vomiting, or diarrhea.
- Blood pressure should be monitored during treatment because venlafaxine can cause sustained increases in blood pressure.
- Report eye pain or vision changes right away, since the label warns about angle-closure glaucoma.
- Ask about sexual side effects if they occur, because decreased libido, delayed orgasm, erectile dysfunction, or ejaculatory delay can happen.
- If you miss a dose or have side effects, contact your prescriber or pharmacist for guidance.
- The label says this medicine is not approved for pediatric patients.
Helpful Patient Education
Venlafaxine tablets, USP are an oral antidepressant indicated for the treatment of major depressive disorder. DailyMed labeling notes important safety information, including the need to monitor for clinical worsening, suicidality, serotonin syndrome, blood pressure increases, and symptoms that can happen when treatment is stopped too quickly.
This product information page is based on the official label for venlafaxine tablets and is intended to support pharmacy education. It also includes key precautions about MAOI use, possible sexual side effects, and the need to use the medicine only as directed by a healthcare professional.
Medication Summary last generated: 2026-07-12 03:09:49
Venlafaxine 50 mg Immediate Release Tablets --- Generic For Effexor --- Zydus may require patient-specific counseling based on your prescription, directions, allergies, medical history, and other medications.
This Medication Guide section is provided for general educational purposes only. It does not replace the official medication guide, patient information leaflet, counseling from your pharmacist, or medical advice from your prescriber.
Please read all information provided with your prescription. Contact Pill Pals Pharmacy or your prescriber with questions before using this medication.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.